Context Therapeutics Inc. (CNTX)
Total Valuation
CNTX has a market cap or net worth of $22.07 million. The enterprise value is $7.62 million.
Market Cap | 22.07M |
Enterprise Value | 7.62M |
Important Dates
The last earnings date was Thursday, March 21, 2024, before market open.
Earnings Date | Mar 21, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CNTX has 15.97 million shares outstanding.
Shares Outstanding | 15.97M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 6.86% |
Owned by Institutions (%) | 30.06% |
Float | 13.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.86 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.83, with zero debt.
Current Ratio | 3.83 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -115.50% and return on invested capital (ROIC) is -211.68%.
Return on Equity (ROE) | -115.50% |
Return on Assets (ROA) | -97.00% |
Return on Capital (ROIC) | -211.68% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.79M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +113.72% in the last 52 weeks. The beta is 2.13, so CNTX's price volatility has been higher than the market average.
Beta (1Y) | 2.13 |
52-Week Price Change | +113.72% |
50-Day Moving Average | 1.11 |
200-Day Moving Average | 1.12 |
Relative Strength Index (RSI) | 67.42 |
Average Volume (30 Days) | 45,414 |
Short Selling Information
The latest short interest is 17,003, so 0.11% of the outstanding shares have been sold short.
Short Interest | 17,003 |
Short Previous Month | 10,782 |
Short % of Shares Out | 0.11% |
Short % of Float | 0.12% |
Short Ratio (days to cover) | 0.33 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -25.13M |
Pretax Income | -23.96M |
Net Income | -23.96M |
EBITDA | -23.90M |
EBIT | -23.96M |
Earnings Per Share (EPS) | -$1.50 |
Balance Sheet
The company has $14.45 million in cash and no debt, giving a net cash position of $14.45 million or $0.91 per share.
Cash & Cash Equivalents | 14.45M |
Total Debt | n/a |
Net Cash | 14.45M |
Net Cash Per Share | $0.91 |
Equity / Book Value | 11.87M |
Book Value Per Share | 0.74 |
Working Capital | 11.86M |
Cash Flow
Operating Cash Flow | -21.05M |
Capital Expenditures | n/a |
Free Cash Flow | -21.05M |
FCF Per Share | -$1.32 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CNTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -108.61% |
FCF Yield | -95.39% |
Analyst Forecast
The average price target for CNTX is $4.00, which is 189.44% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.00 |
Price Target Difference | 189.44% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -7.99% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |